Podcasts

This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. As the omicron variant of SARS-CoV-2 gains attention and generates concern, Dr. Morice and Dr. Pritt discuss what’s being done to learn more about this new variant and the effects it could have on the fight against COVID-19.

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., speaks with Joseph Maleszewski, M.D., the assistant dean of curriculum for Mayo Clinic Alix School of Medicine, about the pathologist’s role in medical education.

This week on "Answers From the Lab," Shannon Bennett, director of Regulatory Affairs for Mayo Clinic’s Department of Laboratory Medicine and Pathology, joins William Morice II, M.D., Ph.D., and Bobbi Pritt, M.D., to discuss tests that are developed by individual laboratories, rather than commercial manufacturers, and how upcoming regulation may affect those tests.

Wei Shen, Ph.D., explains Mayo Clinic Laboratories' new expert-backed, hereditary oncology panels, which use next-generation sequencing to identify genetic mutations linked to increased cancer risk. By only including clinically significant genes, the panels provide clarity on diagnosis, prognosis, and treatment approaches.

This week on the podcast, Elitza Theel, Ph.D., director of Mayo Clinic’s Infectious Diseases Serology Laboratory, joins "Answers From the Lab" with Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Theel discuss antibody testing for COVID-19, including why this testing is done and when it’s most useful.

Audrey Schuetz, M.D., discusses Mayo Clinic Laboratories' PCR assay that identifies two recently described staphylococcus species. The assay is unique in its ability to distinguish the new organisms from Staphylococcus aureus, providing clearer results that ultimately improve patient care.

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., speaks with Philip Hurst, M.D., an anatomic and clinical pathology resident at Mayo Clinic, about the residency interview process and the importance of being authentic.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt discuss the state of COVID-19 now, along with factors that could influence how the pandemic plays out from here.

In this episode of Lab Medicine Rounds, Joseph Yao, M.D., Associate Professor of Laboratory Medicine and Pathology and Medicine, and Assistant Professor of Microbiology at the Mayo Clinic, discusses lessons learned from navigating the current COVID-19 pandemic.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. As cases of COVID-19 fall in some areas of the country and rise in others, Dr. Morice and Dr. Pritt review where the pandemic stands, and emphasize that now is not the time to let our guard down.

In this episode of “Lab Medicine Rounds,” Ann Moyer, M.D., Ph.D., guest hosts Justin Kreuter, M.D., chair of the Mayo Clinic Alix School of Medicine Social Media Committee and a faculty lecturer for Harvard Macy Institute on professional use of social media, to discuss the challenges and opportunities of being a professional on social media.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice talks about his participation in President Biden’s Global COVID-19 Summit and discusses the toll the pandemic has taken on countries around the world.

John Mills, Ph.D., explains Mayo Clinic Laboratories' new neurofascin 155 (NF155) IgG4 antibody test, which is the first commercially available test in the U.S. to use flow cytometry to detect for NF155 antibodies and confirm diagnosis of CIDP.